(Q46765974)

25 December 2017

title

In vivo metabolic activity of CYP2C19 and CYP3A in relation to CYP2C19 genetic polymorphism in chronic liver disease (English)

1 reference

25 December 2017

main subject

chronic liver disease

0 references

author name string

Akihiro Ohnishi

1

1 reference

25 December 2017

Shigeto Murakami

2

1 reference

25 December 2017

Setsuko Akizuki

3

1 reference

25 December 2017

Junko Mochizuki

4

1 reference

25 December 2017

Hirotoshi Echizen

5

1 reference

25 December 2017

Ichiro Takagi

6

1 reference

25 December 2017

publication date

1 November 2005

1 reference

25 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

25 December 2017

volume

45

1 reference

25 December 2017

page(s)

1221-1229

1 reference

25 December 2017

issue

11

1 reference

25 December 2017

Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Selective effect of liver disease on the activities of specific metabolizing enzymes: investigation of cytochromes P450 2C19 and 2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Pre-translational regulation of cytochrome P450 genes is responsible for disease-specific changes of individual P450 enzymes among patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Inheritance and drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Clinical significance of the cytochrome P450 2C19 genetic polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Effect of cytochrome P4502C19 genotypic differences on cure rates for gastroesophageal reflux disease by lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Transection of the oesophagus for bleeding oesophageal varices

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Identification and functional characterization of new potentially defective alleles of human CYP2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Omeprazole drug interaction studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Effect of sex and menstrual cycle phase on cytochrome P450 2C19 activity with omeprazole used as a biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Interphenotype differences in disposition and effect on gastrin levels of omeprazole--suitability of omeprazole as a probe for CYP2C19

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Effects of liver disease on pharmacokinetics. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Single-dose pharmacokinetics of amprenavir, a human immunodeficiency virus type 1 protease inhibitor, in subjects with normal or impaired hepatic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Effect of grapefruit juice on urinary 6 beta-hydroxycortisol/cortisol excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Expression of cytochrome P450 3A in amphibian, rat, and human kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Inhibition of drug metabolism in human liver microsomes by nizatidine, cimetidine and omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

Omeprazole does not affect measured CYP3A4 activity using the erythromycin breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005280787

21 January 2018

Identifiers

DOI

10.1177/0091270005280787

1 reference

25 December 2017

PubMed ID

16239354

1 reference

25 December 2017